stroke like symptoms; weakness; clumsiness; cough; dizziness; shortness of breath; fatigue; altered gait; dropping things/trouble bathing; malaise; mood swing; nausea; pain; changes in speech; inability to walk on own; Booster; This is a spontaneous report received from contactable reporter consumer. The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 02Dec2021 16:30 (Lot number: FK5618) at the age of 43 years as dose 3 (booster), single for covid-19 immunisation; tetanus vaccine (TETANUS VACCINE), administered in arm left, administration date 23Nov2021 (Batch/Lot number: unknown). Relevant medical history included: "tbi" (unspecified if ongoing); "encephomalcia" (unspecified if ongoing); "asthma" (unspecified if ongoing); "sulfa" (unspecified if ongoing). Concomitant medication(s) included: HYDROCODONE; DIAZEPAM; DOXYCYCLINE; PREDNISONE. Past drug history included: Morphine, reaction(s): "allergy"; Paxil, reaction(s): "allergy"; Effexor, reaction(s): "allergy"; Cymbalta, reaction(s): "allergy"; Topimax, reaction(s): "allergy". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: FF2590, Location of injection: Arm Right, Vaccine Administration Time: 11:00 AM), administration date: 22Apr2021, when the patient was 43 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EW0150, Location of injection: Arm Left, Vaccine Administration Time: 11:30 AM), administration date: 2021, for COVID-19 immunization. The following information was reported: IMMUNISATION (medically significant) with onset 02Dec2021 14:30, outcome "unknown", described as "Booster"; CEREBROVASCULAR ACCIDENT (medically significant) with onset 05Dec2021 14:00, outcome "not recovered", described as "stroke like symptoms"; ASTHENIA (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "weakness"; CLUMSINESS (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "clumsiness"; COUGH (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "cough"; DIZZINESS (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "dizziness"; DYSPNOEA (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "shortness of breath"; FATIGUE (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "fatigue"; GAIT DISTURBANCE (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "altered gait"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "dropping things/trouble bathing"; MALAISE (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "malaise"; MOOD SWINGS (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "mood swing"; NAUSEA (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "nausea"; PAIN (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "pain"; SPEECH DISORDER (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "changes in speech"; WALKING DISABILITY (non-serious) with onset 05Dec2021 14:00, outcome "not recovered", described as "inability to walk on own". The events "stroke like symptoms", "weakness", "clumsiness", "cough", "dizziness", "shortness of breath", "fatigue", "altered gait", "dropping things/trouble bathing", "malaise", "mood swing", "nausea", "pain", "changes in speech" and "inability to walk on own" were evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of event included antibiotics. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19, unknown result.